Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

SULFABID

SULFAPHENAZOLE

Standard Dose
500MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview SULFABID is listed in Drugs@FDA under application 013092 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient SULFAPHENAZOLE Form and strength TABLET;ORAL - 500MG Sponsor PURDUE FREDERICK Submission history Latest submission status date: 1978-08-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview SULFABID is listed in Drugs@FDA under application 013092 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient SULFAPHENAZOLE Form and strength TABLET;ORAL - 500MG Sponsor PURDUE FREDERICK Submission history Latest submission status date: 1978-08-09 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.